SIGA Technologies, Inc. (SIGA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about SIGA Technologies, Inc. (SIGA)
Go deeper and ask any question about SIGA
Company Performance
Current Price
as of Sep 13, 2024$7.90
P/E Ratio
6.69
Market Cap
$563.82M
Description
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
Metrics
Overview
- HQNew York, NY
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerSIGA
- Price$7.9+0.38%
Trading Information
- Market Cap$563.82M
- Float56.81%
- Average Daily Volume (1m)1,309,722
- Average Daily Volume (3m)1,430,951
- EPS$1.18
Company
- Revenue$172.96M
- Rev Growth (1yr)271.05%
- Net Income$1.83M
- Gross Margin43.55%
- EBITDA Margin5.60%
- EBITDA$1.22M
- EV$439.28M
- EV/Revenue2.54
- P/E6.69
- P/S3.28
Documents
SEC Filings
Earnings Calls
Factset Street Account